Skyworks Solutions (SWKS) PT Raised to $195 at Susquehanna

Pre-Open Movers 07/30: (ERYP) (TEAM) (MSON) Higher; (PINS) (ZYXI) (AMZN) Lower (more...)

Pre-Open Stock Stock Movers:

ERYTECH Pharma (Nasdaq: ERYP) 99% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted eryaspase Fast Track designation for the treatment of acute lymphocytic leukemia (ALL) patients who have developed hypersensitivity reactions to E. coli-derived pegylated asparaginase (PEG-ASNase).

Pinterest (NYSE: PINS) 20% LOWER; reported Q2 EPS of $0.25, $0.12 better than the analyst estimate of $0.13. Revenue for the quarter came in at $613 million versus the consensus estimate of $561.88 million.... More

Skyworks Solutions (SWKS) PT Raised to $255 at Needham & Company

Needham & Company analyst Rajvindra S. Gill raised the price target on Skyworks Solutions (NASDAQ: SWKS) to $255.00 (from $245.00) while maintaining a Buy rating.

The analyst commented, "Skyworks reported revenues in-line and guided Q4-21 sales to $1.3B (vs. $1.2B Needham and $1.4B consensus), and non-GAAP EPS... More

Skyworks Solutions (SWKS) PT Raised to $215 at Mizuho Securities

Mizuho Securities analyst Vijay Rakesh raised the price target on Skyworks Solutions (NASDAQ: SWKS) to $215.00 (from $210.00) while maintaining a Buy rating.... More

Skyworks Solutions (SWKS) PT Raised to $204 at Morgan Stanley

Morgan Stanley analyst Craig Hettenbach raised the price target on Skyworks Solutions (NASDAQ: SWKS) to $204.00 (from $192.00) while maintaining a Equalweight rating.... More

After-Hours Stock Movers 07/29: (ERYP) (TEAM) (MSON) Higher; (PINS) (ZYXI) (AMZN) Lower (more...)

After-Hours Stock Movers:

ERYTECH Pharma (Nasdaq: ERYP) 133% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted eryaspase Fast Track designation for the treatment of acute lymphocytic leukemia (ALL) patients who have developed hypersensitivity reactions to E. coli-derived pegylated asparaginase (PEG-ASNase).

Pinterest (NYSE: PINS) 19% LOWER; reported Q2 EPS of $0.25, $0.12 better than the analyst estimate of $0.13. Revenue for the quarter came in at $613 million versus the consensus estimate of $561.88 million. Global Monthly Active Users... More

Skyworks Solutions (SWKS) Tops Q3 EPS by 1c

Skyworks Solutions (NASDAQ: SWKS) reported Q3 EPS of $2.15, $0.01 better than the analyst estimate of $2.14. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.1 billion.

GUIDANCE:

Skyworks Solutions sees Q4 2021 EPS of $2.53-$2.48. Skyworks Solutions sees Q4 2021... More